000 01451 a2200385 4500
005 20250516050409.0
264 0 _c20111207
008 201112s 0 0 eng d
022 _a1944-7884
024 7 _a10.1097/QAI.0b013e31822ccfcc
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aButler, Scott L
245 0 0 _aDisease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy.
_h[electronic resource]
260 _bJournal of acquired immune deficiency syndromes (1999)
_cNov 2011
300 _a297-303 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-HIV Agents
_xadministration & dosage
650 0 4 _aAntiretroviral Therapy, Highly Active
_xmethods
650 0 4 _aClinical Trials as Topic
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadministration & dosage
700 1 _aValdez, Hernan
700 1 _aWestby, Michael
700 1 _aPerros, Manos
700 1 _aJune, Carl H
700 1 _aJacobson, Jeffrey M
700 1 _aLevy, Yves
700 1 _aCooper, David A
700 1 _aDouek, Daniel
700 1 _aLederman, Michael M
700 1 _aTebas, Pablo
773 0 _tJournal of acquired immune deficiency syndromes (1999)
_gvol. 58
_gno. 3
_gp. 297-303
856 4 0 _uhttps://doi.org/10.1097/QAI.0b013e31822ccfcc
_zAvailable from publisher's website
999 _c21038341
_d21038341